Stocks
GlaxoSmithKline (GSK) ROA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | 5 years average | |||
| ROA, % | ? | 4.09% | 24.9% | 6.55% | 4.33% | 9.37% | 7.03% | ||
| Changes by years, y/y, % | -1pp | +21pp | -18pp | -2pp | +5pp | 10% | |||
GlaxoSmithKline. ROA, %
GlaxoSmithKline. ROA, changes, pp
GlaxoSmithKline (GSK) ROA US GAAP (quarter values) |
||||||||
| FY2025Q4 | FY2025Q4 | FY2026Q1 | FY2026Q2 | FY2026Q2 | LTM ? | |||
| ROA, % | ? | 9.37% | 9.37% | 7.03% | 7.86% | 7.86% | 7.03% | |
| Changes by years, y/y, % | +5pp | +5pp | +3pp | +4pp | +4pp | |||
| Changes by quarters, q/q, % | +3pp | 0pp | -2pp | +1pp | 0pp | |||
